Novavax, Inc. (NVAX) reported that net loss for the third quarter was $7.53 million, or $0.08 per share, compared to a net loss of $7.84 million, or $0.12 per share, for the same period last year.
Loss from continuing operations was $7.53 million or $0.08 per share, narrower than $10.33 million or $0.16 per share in the prior year quarter.
Total revenues grew to $201 thousand from $194 thousand in the same quarter last year.
On average, 3 analysts polled by Thomson Reuters expected the company to report loss of $0.09 per share, on revenues of $30 thousand. Analysts' estimates typically exclude special items.
For comments and feedback: editorial@rttnews.com